RecallCheckr

Serious recall: Injury is possible or has been reported. Take action promptly.

Viatris Inc 2022-05-11 Health serious FDA
Health · FDA · Recall #FDA-D-0844-2022

alprazolam XR extended-release tablets, 3 mg, 60-count bottle, Rx only, Distributed by:… Recall

Issued May 11, 2022 · Viatris Inc

In May 2022, Viatris Inc recalled the alprazolam XR extended-release tablets, 3 mg, 60-count bottle, Rx only, Distributed by:…, a serious health recall reported by the FDA.

Compiled by Maya Ellison, RecallCheckr

What this means for you

Failed Dissolution Specifications: low out-of-specification dissolution test results observed.

What you should do

  1. 1 Stop using alprazolam XR extended-release tablets, 3 mg, 60-count bottle, Rx only, Distributed by:… right away.
  2. 2 Set it aside where it won't be used by mistake.
  3. 3 Contact Viatris Inc to arrange your voluntary. See the official notice below for contact details.
  4. 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):

Recall details

Brand
Viatris Inc
Category
Health
Recall date
May 11, 2022
Units affected
Not reported
Sold at
Product was distributed nationwide in the USA
Recall number
FDA-D-0844-2022
Made in
United States
Issuing agency
FDA

In context

  • Viatris Inc has 9 recalls in our database.
  • We're tracking 3,576 Health recalls in our database.
  • This is the 870th Health recall we've logged in 2022.
Read the official FDA notice

Related recalls